Traumatic Rotator Cuff Tear Clinical Trial
— SPeEDyOfficial title:
Surgery Versus PhysiothErapist-leD Exercise for Traumatic Tears of the Rotator Cuff: a Multi-site Pilot and Feasibility Randomised Controlled Trial (the SPeEDy Study)
Verified date | February 2021 |
Source | Keele University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The SPeEDy study is a parallel group, pilot and feasibility randomised controlled trial (RCT) with integrated Quintet Recruitment Intervention (QRI) and further qualitative interviews. The study hypothesis is: In adult patients diagnosed with traumatic tears of the rotator cuff, is it feasible to conduct a future, substantive, multi-site RCT to test the hypothesis that physiotherapist-led exercise is not inferior to surgical repair of the rotator cuff in terms of clinical outcomes but is more cost-effective.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | February 3, 2021 |
Est. primary completion date | February 3, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Adult patients (=18 years) 2. Diagnosed with a symptomatic tear of the rotator cuff following a traumatic incident thought to be of sufficient force to induce a tear. 3. Rotator cuff tear confirmed by diagnostic ultrasound or MRI scan undertaken as part of routine diagnostic work-up 4. Eligible for rotator cuff repair surgery or a programme of physiotherapist-led exercise as determined by the attending clinician (surgeon or physiotherapist, where appropriate) 5. Able to return to the participating NHS hospital or associated orthopaedic and physiotherapy services (where physiotherapists have been trained in trial interventions) for post-operative rehabilitation or the programme of physiotherapist-led exercise. 6. Able to understand English. Exclusion Criteria: 1. Not eligible for rotator cuff repair surgery or a programme of physiotherapist-led exercise as determined by the attending clinician (surgeon or physiotherapist, where appropriate) 2. Patients who are unable to give full informed consent. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University Hospital of Derby & Burton NHS | Derby |
Lead Sponsor | Collaborator |
---|---|
Keele University | Airedale NHS Foundation Trust, Liverpool University Hospitals NHS Foundation Trust, National Institute for Health Research, United Kingdom, Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust, University Hospital Birmingham NHS Foundation Trust, University Hospitals Coventry and Warwickshire NHS Trust, University Hospitals of Derby and Burton NHS Foundation Trust, University Hospitals of North Midlands NHS Trust, University Hospitals, Leicester |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of recruiting participating sites and numbers of additional sites who are interested in participating in the main trial | Number of recruiting participating sites and numbers of additional sites who are interested in participating in the main trial will be recorded descriptively | Whole study period, 36 months | |
Other | Number and type of adverse events | Number and type of adverse events will be recorded descriptively following patient or clinician report | Up to six months post-randomisation | |
Primary | Numbers of patients screened, number eligible, number approached, number consenting, number randomised, and number accepting allocation | Numbers of patients screened, number eligible, number approached, number consenting, number randomised, and number accepting allocation will be recorded descriptively | Over recruitment period, 15 months | |
Primary | Numbers of participants continuing in allocated treatment | Numbers of participants continuing in allocated treatment will be recorded descriptively | Six months | |
Primary | Follow-up response rates to questionnaires (including Oxford Shoulder Score and EQ-5D-5L) | Follow-up response rates to questionnaires will be recorded descriptively | Three months post-randomisation | |
Primary | Follow-up response rates to questionnaires (including Oxford Shoulder Score and EQ-5D-5L) | Follow-up response rates to questionnaires will be recorded descriptively | Six months post-randomisation | |
Primary | Determination of zone of clinical equipoise | Data from screening logs, including reasons for not approaching potentially eligible patients will be recorded descriptively to inform determination of zone of clinical equipoise | Over recruitment period, 15 months | |
Primary | Treatment cross-over | Numbers of participants receiving treatment (surgery or PT-led exercise) other than that which was allocated to determine proportion of participants who cross-over will be recorded descriptively | Six months | |
Primary | Participant satisfaction with the interventions: five-point ordinal scale | Participant satisfaction with the interventions on a five-point ordinal scale; Very Satisfied/Satisfied/Neutral/Dissatisfied/Very Dissatisfied | Six months | |
Secondary | Pain and disability assessed using the Oxford Shoulder Score (OSS) | The OSS is a 12-item shoulder-specific self-report measure of shoulder pain and function primarily for the assessment of outcome of shoulder surgery in RCTs. The OSS is reliable, valid, responsive and acceptable to patients. The items refer to the past 4 weeks with five ordinal response options scored from 0 to 4, with 4 representing the best outcome. When the 12 items are summed, this produces an overall score ranging from 0 to 48, with 48 being the best outcome. | Three and six months post-randomisation | |
Secondary | Health related quality of life assessed using the EQ-5D-5L | The EQ-5D-5L is a generic measure of health related quality of life that provides a single index value for health status that can be used for the purpose of clinical and health economic evaluation. The EQ-5D-5L consists of questions relating to five health domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and respondents rate their degree of impairment using five response levels (no problems, slight problems, moderate problems, severe problems and extreme problems). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. A total of 3125 possible health states can be defined in this way which can then be converted in to a single index value between 0 and 1, | Three and six months post-randomisation | |
Secondary | Days lost from work due to the shoulder problem | Days lost from work due to the shoulder problem will be recorded descriptively on a self-report questionnaire | Three and six months post-randomisation | |
Secondary | Time taken to return to driving | Time taken to return to driving will be recorded descriptively on a self-report questionnaire | Three and six months post-randomisation |